During EBV‐associated PTLD, the activation of EBV‐specific CD8+ T cells acts as a potent cancer suppressor, exerting cytotoxic effects early in the infection and maintaining EBV suppression over time.162. Here, CD8A is linked to post-transplant lymphoproliferative disease.